# 5T Torino (Italy)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/5t-torino-italy/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 88 |
| Citations | 66,316 |
| City | Turin |
| Country | IT |
| Description | 5T Torino (Italy) is a research organisation in Turin, IT. OpenAlex records 1,710 works and 66,316 citations for it. 504 researchers list it as their most recent affiliation. |
| Homepage | http://www.5t.torino.it/ |
| OpenAlex ID | https://openalex.org/I4210095558 |
| Researchers | 504 |
| ROR ID | https://ror.org/00k7znw93 |
| Type | company |
| Works | 1,710 |

## University papers

- [Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma](https://scholariq.org/papers/idecabtagene-vicleucel-in-relapsed-and-refractory-multiple-myeloma/)
- [Microbiome definition re-visited: old concepts and new challenges](https://scholariq.org/papers/microbiome-definition-re-visited-old-concepts-and-new-challenges/)
- [Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”](https://scholariq.org/papers/consensus-definition-of-sarcopenia-cachexia-and-pre-cachexia-joint-document/)
- [Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME](https://scholariq.org/papers/recent-advances-in-2d-and-3d-in-vitro-systems-using-primary-hepatocytes/)
- [Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma](https://scholariq.org/papers/lenalidomide-and-dexamethasone-in-transplant-ineligible-patients-with-myeloma/)
- [Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma](https://scholariq.org/papers/ide-cel-or-standard-regimens-in-relapsed-and-refractory-multiple-myeloma/)
- [Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma](https://scholariq.org/papers/daratumumab-bortezomib-lenalidomide-and-dexamethasone-for-multiple-myeloma/)
- [Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/pembrolizumab-plus-pomalidomide-and-dexamethasone-for-patients-with-relapsed-or/)
- [LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma](https://scholariq.org/papers/locommotion-a-prospective-non-interventional-multinational-study-of-real-life/)
- [International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation](https://scholariq.org/papers/international-myeloma-working-group-guidelines-for-the-management-of-multiple/)

## University top topics

Showing 8 of 23.

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Corporate Finance and Governance](https://scholariq.org/topics/corporate-finance-and-governance/)
- [Gender, Labor, and Family Dynamics](https://scholariq.org/topics/gender-labor-and-family-dynamics/)
- [Financial Literacy, Pension, Retirement Analysis](https://scholariq.org/topics/financial-literacy-pension-retirement-analysis/)
- [Labor market dynamics and wage inequality](https://scholariq.org/topics/labor-market-dynamics-and-wage-inequality/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Mycorrhizal Fungi and Plant Interactions](https://scholariq.org/topics/mycorrhizal-fungi-and-plant-interactions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.